Search Results
May 29, 2026, 08:18 ET New TECVAYLI® (teclistamab-cqyv) data demonstrate superior progression-free and overall survival as early as first relapse in multiple myeloma
TECVAYLI®TECVAYLI® (teclistamab-cqyv) is a first-in-class, bispecific T-cell engager antibody therapy that uses innovative science to activate the immune system by binding to the CD3 receptor expressed on the surface of T-cells and to the B-cell maturation antigen (BCMA) expressed on the surface
More news about: Johnson & Johnson
May 29, 2026, 08:15 ET PeproMene Bio annonce une présentation orale à l'EHA 2026 mettant en évidence un profil de sécurité favorable et des réponses durables avec la PMB-CT01 (thérapie CAR-T anti-BAFF-R) dans les lymphomes à cellules B, y compris après l'échec d'une thérapie CAR-T CD19 antérieure
progressé après une thérapie CAR-T CD19, a obtenu une réponse complète lors de sa première évaluation de la maladie. Le tFL est une forme agressive de lymphome pour laquelle les options thérapeutiques sont limitées.« Lorsque le cancer progresse après une thérapie CAR-T anti-CD19, les patients sont
More news about: PeproMene Bio, Inc.
May 29, 2026, 08:00 ET AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
interventions, including small molecule therapeutics, antibody-drug conjugates (ADCs), immuno-oncology-based therapeutics, multispecific antibody and novel CAR-T platforms. Our dedicated and experienced team joins forces with innovative partners to accelerate the delivery of potential breakthrough medicines.Today,
More news about: AbbVie
May 29, 2026, 08:00 ET AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
interventions, including small molecule therapeutics, antibody-drug conjugates (ADCs), immuno-oncology-based therapeutics, multispecific antibody and novel CAR-T platforms. Our dedicated and experienced team joins forces with innovative partners to accelerate the delivery of potential breakthrough medicines.Today,
More news about: AbbVie
May 29, 2026, 07:41 ET Fairmont Hotels & Resorts debuta en el noroeste de Inglaterra con Fairmont Cheshire, The Mere
T. +44(0) 1565 830155Contacto para restaurantes [email protected]T. +44(0) 1565 830155Reservas MICE
More news about: Fairmont Hotels & Resorts
May 29, 2026, 07:01 ET SHINE Secures European Marketing Authorization for Ilumira, Latest Step in Building Integrated Nuclear Medicine Platform
https://world-nuclear.org/information-library/non-power-nuclear-applications/radioisotopes-research/radioisotopes-in-medicine[2] Niu T, Fan M, Lin B, et al. Current clinical application of lutetium-177 in solid tumors (Review). Exp Ther Med. 2024;27(5):225. doi:10.3892/etm.2024.12514.
More news about: SHINE Technologies, LLC
May 29, 2026, 06:53 ET AI and Content Reshape Attractions & Tours at Trip.com Group's Global Partner Forum
May 29, 2026 /PRNewswire/ -- Trip.com Group, a leading global travel service provider, explored the future of the Attractions & Tours (A&T) sector at the Attractions & Tours Global Partners Forum, part of the Group's annual Envision.2026 conference.Held at the prestigious Shanghai
More news about: Trip.com Group
May 29, 2026, 03:14 ET EngineAI Launches Shenzhen Intelligent Manufacturing Base as First Batch of T800 Humanoid Robots Roll Off the Production Line to Begin Mass Delivery
official launch of EngineAI Intelligent Manufacturing (Honghualing, Shenzhen) Base, alongside the rollout of the first batch of its flagship T800 full-size humanoid robots. This milestone marks the company's decisive entry into a new phase of 10,000-unit scalable delivery capability.
More news about: EngineAI
May 29, 2026, 03:01 ET FAIRMONT HOTELS & RESORTS DEBUTS IN NORTHWEST ENGLAND WITH FAIRMONT CHESHIRE, THE MERE
T. +44(0) 1565 830155Contact for restaurants [email protected] T. +44(0) 1565 830155MICE bookings
More news about: Fairmont Hotels & Resorts
May 29, 2026, 02:19 ET EngineAI Launches Shenzhen Intelligent Manufacturing Base as First Batch of T800 Humanoid Robots Roll Off the Production Line to Begin Mass Delivery
official launch of EngineAI Intelligent Manufacturing (Honghualing, Shenzhen) Base, alongside the rollout of the first batch of its flagship T800 full-size humanoid robots. This milestone marks the company's decisive entry into a new phase of 10,000-unit scalable delivery capability.
More news about: EngineAI
May 29, 2026, 02:05 ET Sivers Semiconductors AB (publ), Publishes Interim Report Q1, January - March 2026
applicationsStrategic and Operational Highlights after the end of the period:Announced collaboration with Jabil on 1.6T Pluggable Transceiver ModuleIndicated Board consideration for potential U.S. dual listingTachyon Networks expanded FWA Portfolio with
More news about: Sivers Semiconductors
May 29, 2026, 02:03 ET 硬件打破極限：Evnia攜手京東方發佈全球首款原生1000Hz真千幀電競顯示器
全球電競顯示技術迎來顛覆性跨越！飛利浦（Philips）旗下高端電競品牌 Evnia，近日攜手全球顯示巨頭京東方（BOE）於技術發佈會上，重磅揭曉標杆級旗艦新品——Evnia 原生 FHD IPS真千幀護眼電競顯示器 25M4P5200T。作為全球首款在硬件層面實現原生 1000Hz 刷新率的頂級裝備，該產品不僅重構了高刷競技的天花板，更宣告電競顯示正式邁入「真千幀、不失真」的全新紀元。
More news about: Evnia
May 29, 2026, 02:00 ET TOMY to Launch First Ultrasaurus Model Featuring Gravity Cannon: ZOIDS "AZ-17DX ULTRA SAURUS GRAVITY CANNON Ver." Set for Late February 2027 Release
stores, and the official online store, TOMY MALL, among othersT-SPARK Opens First Brand Store in Hong KongExpanding Opportunities to Experience the Brand GloballyT-SPARK opened its first standalone brand store, "T-SPARK ZONE HONGKONG," in Hong Kong on May 1, 2026. The brand is actively
More news about: TOMY Company, Ltd.
May 29, 2026, 01:01 ET PeproMene Bio anuncia una presentación oral en EHA 2026 donde destacará el PMB-CT01 en linfomas de células B
donde destacará la seguridad favorable y las respuestas duraderas con PMB-CT01 (terapia con células T CAR BAFF-R) en linfomas de células B, incluso después de un fracaso previo de la terapia con células T CAR CD19IRVINE, California, 29
More news about: PeproMene Bio, Inc.
May 29, 2026, 00:55 ET 페프로민 바이오, 이전 CD19 CAR T세포 치료 실패 후를 포함한 B세포 림프종에서 PMB-CT01(BAFF-R CAR T세포 치료제)의 우수한 안전성과 지속적인 반응을 강조하는 EHA 2026 구두 발표 예고
확장 코호트 환자 등록을 활발히 진행하고 있다. 특히 이번 확장 단계에서 치료를 받은 첫 번째 환자인 CD19 CAR T 치료 후 질병이 진행된 형질전환 FL(transformed FL, tFL) 환자는 첫 번째 질병 평가에서 CR에 도달했다. tFL은 확립된 치료 옵션이 제한적인 공격적 형태의 림프종이다.페프로민 바이오의 과학 창립자인 래리 W. 쿽(Larry W. Kwak) 의학박사는 "CD19 CAR T 치료 후 암이 진행될 경우, 환자들은 남아 있는 치료 옵션이 매우 제한적이라는 중대한 미충족 의료 수요에 직면한다"며
More news about: PeproMene Bio, Inc.
May 29, 2026, 00:37 ET 小米發佈全新準旗艦 Xiaomi 17T Series
/美通社/ -- 小米今日為其 T Series智能手機產品線增添新成員，推出全新 Xiaomi 17T Series，包括 Xiaomi 17T 及 Xiaomi 17T Pro。Xiaomi 17T Series 結合了同價位唯一Leica Summilux 5倍光學長焦鏡頭、首個德國萊因TÜV四重護眼認證顯示屏，其中Xiaomi 17T Pro 更配備小米手機線史上最大電池容量：7000mAh高能量矽碳電池 和 同價位唯一提供1TB 內存容量；Xiaomi 17T Series以精緻設計的機身承載影像旗艦體驗。此系列首次為 T Series 引入雙尺寸選擇，專為現代不同用戶打造非凡體驗。
More news about: Xiaomi Hong Kong
May 28, 2026, 23:31 ET /C O R R E C T I O N -- People Science, Inc./
More news about: People Science, Inc.
May 28, 2026, 19:26 ET Phanes Therapeutics Announces Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting
an emerging class of immuno-oncology (IO) agents. Unlike immune checkpoint inhibitors (ICIs) (also known as anti-PD1/anti-PD-L1 drugs) which activate T cells to kill cancer cells, I2Es activate macrophages and dendritic cells to recognize and destroy cancer cells, providing an alternative mechanism
More news about: Phanes Therapeutics, Inc.
May 28, 2026, 19:10 ET FDA approves label expansion, cementing TREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage
https://clinicaltrials.gov/study/NCT04882098. Accessed May 2026.11 Donvito T., CreakyJoints: What Is Dactylitis? The 'Sausage Finger' Swelling You Should Know About. Available at:
More news about: Johnson & Johnson
May 28, 2026, 18:49 ET Données Omdia pour le T1 2026 : Hisense renforce son leadership mondial dans le domaine des téléviseurs de plus de 100 pouces
content:https://www.prnewswire.com/news-releases/donnees-omdia-pour-le-t1-2026--hisense-renforce-son-leadership-mondial-dans-le-domaine-des-televiseurs-de-plus-de-100-pouces-302785096.html
More news about: Hisense
May 28, 2026, 17:30 ET "No Pathways, No Pipeline" makes No Sense says Friends of Science Society Citing Global Energy Shortfall and No Climate Emergency
celebrated the fact that the agreement means the industrial carbon tax in Alberta is set to rise six-fold from a current trading baseline price of some $20/t. A full schedule is laid out in the
More news about: Friends of Science Society
May 28, 2026, 16:03 ET /C O R R E C T I O N -- 100 Billion Meals/
More news about: 100 Billion Meals